Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New U.S. patent covers use of anti-CTGF antibodies to treat fibrotic disorders

Oct. 19, 1998

First FDA approval for once-daily use of an inhaled corticosteroid for asthma

Oct. 16, 1998

Collaborative agreements in the field of asthma signed by SkyePharma and Sepracor

Oct. 15, 1998

Trega concludes phase I testing of HP-228 inhalation formulation

Oct. 13, 1998

Neutrophil inhibitor peptides available for licensing from RCT

Oct. 13, 1998

FDA continues to support development of SciClone's CF Rx

Oct. 9, 1998

HMR announces Spanish launch of Telfast

Oct. 9, 1998

Anti-IgE antibody in the treatment of asthma: an interesting theory is validated

Oct. 8, 1998

Genotyping accurately predicts response to treatment with 5-LO inhibitor

Oct. 8, 1998

PAF antagonists in the treatment of asthma: promise or hype?

Oct. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.